Related Experiment Video
Updated: Jul 12, 2025

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
19.7K
Percutaneous Removal of Left Atrial Myxoma: The FLORIDA Procedure
Goyal Umadat1, Charlene Rohm1, Prajwal Reddy1
1Department of Cardiovascular Disease, Mayo Clinic, Jacksonville, Florida, USA.
JACC. Case Reports
|October 23, 2023
Abstract:
Surgical resection has been the treatment of choice for cardiac myxomas, but older age and comorbidities relegate many patients to observation. Pure percutaneous removal of left atrial myxomas is both intriguing and challenging. We report a successful percutaneous technique for removal of left atrial cardiac myxoma in a nonsurgical candidate. (Level of Difficulty: Advanced.).
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiac Catheterization III: Left Heart Catheterization
23
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
23

